Nephros (NEPH) Free Cash Flow (2010 - 2026)
Nephros (NEPH) posted quarterly Free Cash Flow of -$1.7 million for Q1 2026, down 618.94% year-over-year from $322000.0 in Q1 2025, and down 1003.24% quarter-over-quarter from $185000.0 in Q4 2025.
Nephros (NEPH) Free Cash Flow (2010 - 2026) Analysis & Trends
Nephros' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 618.94% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$393000.0 (down 178.29% YoY), while the FY2025 annual figure was $1.6 million, up 392.5% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$1.7 million, down from $185000.0 in the prior quarter.
- The five-year high for Free Cash Flow was $1.3 million in Q4 2024, with the low at -$1.8 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$170000.0 (2022), against an average of -$182764.7.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow slumped 2247.44% in 2022, then surged 577.66% in 2024.
- Nephros' Free Cash Flow stood at -$195000.0 in 2022, then sank by 40.0% to -$273000.0 in 2023, then soared by 577.66% to $1.3 million in 2024, then plunged by 85.81% to $185000.0 in 2025, then plunged by 1003.24% to -$1.7 million in 2026.
- Business Quant data shows NEPH's Free Cash Flow at -$1.7 million in Q1 2026, $185000.0 in Q4 2025, and $99000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 948.40 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 633.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 136.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 403.50 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 604.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 80.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 144.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 96.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 181.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 681,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 681,000.00 |
| Jun 30, 2026 | 681,000.00 |
| Mar 31, 2026 | -1.67 Mn |
| Mar 31, 2026 | -1.67 Mn |
| Dec 31, 2025 | 185,000.00 |
| Dec 31, 2025 | 185,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | 994,000.00 |
| Jun 30, 2025 | 994,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | -623,000.00 |
| Sep 30, 2024 | -623,000.00 |
| Jun 30, 2024 | -501,000.00 |
| Jun 30, 2024 | -501,000.00 |
| Mar 31, 2024 | -672,000.00 |
| Mar 31, 2024 | -672,000.00 |